0000899243-19-013497.txt : 20190514 0000899243-19-013497.hdr.sgml : 20190514 20190514184907 ACCESSION NUMBER: 0000899243-19-013497 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190507 FILED AS OF DATE: 20190514 DATE AS OF CHANGE: 20190514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ryan David Terrence CENTRAL INDEX KEY: 0001776567 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12658 FILM NUMBER: 19824407 MAIL ADDRESS: STREET 1: 8904 HIGHFIELD ROAD CITY: RICHMOND STATE: VA ZIP: 23229 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBEMARLE CORP CENTRAL INDEX KEY: 0000915913 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821] IRS NUMBER: 541692118 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4350 CONGRESS STREET STREET 2: SUITE 700 CITY: CHARLOTTE STATE: NC ZIP: 28209 BUSINESS PHONE: 980-299-5700 MAIL ADDRESS: STREET 1: 4350 CONGRESS STREET STREET 2: SUITE 700 CITY: CHARLOTTE STATE: NC ZIP: 28209 FORMER COMPANY: FORMER CONFORMED NAME: ECHEM INC DATE OF NAME CHANGE: 19931208 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2019-05-07 0 0000915913 ALBEMARLE CORP ALB 0001776567 Ryan David Terrence ALBEMARLE CORPORATION 4250 CONGRESS STREET,SUITE 900 CHARLOTTE NC 28209 0 1 0 0 VP, Corp. Strategy & IR Common Stock 651 D Restricted Stock Unit Common Stock 2473 D Stock Option 91.00 Common Stock 2707 D Restricted Stock Units Common Stock 808 D Restricted Stock Units Common Stock 632 D Restricted Stock Units Common Stock 826 D On May 12, 2016, the reporting person was granted 2,473 Restricted Stock Units, fully vesting in one installment on the third anniversary of the grant date. Restricted Stock Units converted into Common Stock on a one-for-one basis. On February 26, 2019, the reporting person was granted a 10-year option exercisable for 2,707 shares of Common Stock, cliff-vesting on February 26, 2022. Restricted Stock Units granted on 2/24/2017. First 50% vests on 2/24/2020 and second 50% vests on 2/24/2021. No expiration date. Restricted Stock Units granted on 2/23/2018. First 50% vests on 2/23/2021 and second 50% vests on 2/23/2022. Restricted Stock Units granted on 2/26/2019. First 50% vests on 2/26/2022 and second 50% vests on 2/26/2023. Exhibit List Exhibit 24 - Power of Attorney /s/ Ander Krupa, attorney-in-fact 2019-05-14 EX-24 2 attachment1.htm EX-24 DOCUMENT



                               POWER OF ATTORNEY

     Know all by these presents, that the undersigned hereby constitutes and
appoints each of Karen G. Narwold, Ander Krupa, Sarah E. Marshik and Brenda J.
Mareski, or either of them acting singly and with full power of substitution,
the undersigned's true and lawful attorney-in-fact to:


     (1)  execute for and on behalf of the undersigned, in the
          undersigned's capacity as an officer and/or director of Albemarle
          Corporation (the "Company"), Forms 3, 4 and 5 in accordance with
          Section 16(a) of the Securities Exchange Act of 1934 and the rules
          thereunder;
     (2)  do and perform any and all acts for and on behalf of the
          undersigned that may be necessary or desirable to complete and execute
          any such Form 3, 4 or 5, complete and execute any amendment or
          amendments thereto, and timely file such form with the United States
          Securities and Exchange Commission and any stock exchange or similar
          authority; and
     (3)  take any other action of any type whatsoever in connection
          with the foregoing that, in the opinion of such attorney-in-fact, may
          be of benefit to, in the best interest of, or legally required by, the
          undersigned, it being understood that the documents executed by such
          attorney-in-fact on behalf of the undersigned pursuant to this Power
          of Attorney shall be in such form and shall contain such terms and
          conditions as such attorney-in-fact may approve in such attorney-in-
          fact's discretion.

     The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.

     This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 9th day of May, 2019.



                                             /s/ David Terrence Ryan
                                             ------------------------------
                                             David Terrence Ryan